S&P 500   3,127.79 (-0.01%)
DOW   27,036.83 (-0.16%)
QQQ   217.04 (+0.78%)
AAPL   292.44 (+1.51%)
MSFT   170.50 (+1.45%)
GOOGL   1,397.80 (+0.83%)
AMZN   1,982.17 (+0.48%)
CGC   19.83 (+1.07%)
NVDA   267.60 (+2.12%)
BABA   210.17 (+2.21%)
MU   52.38 (+0.52%)
GE   10.91 (-3.71%)
AMD   47.75 (+0.38%)
T   37.29 (-0.16%)
ACB   1.52 (+0.66%)
F   7.26 (+0.28%)
NFLX   378.54 (+5.12%)
BAC   30.75 (-1.06%)
DIS   123.43 (-3.71%)
S&P 500   3,127.79 (-0.01%)
DOW   27,036.83 (-0.16%)
QQQ   217.04 (+0.78%)
AAPL   292.44 (+1.51%)
MSFT   170.50 (+1.45%)
GOOGL   1,397.80 (+0.83%)
AMZN   1,982.17 (+0.48%)
CGC   19.83 (+1.07%)
NVDA   267.60 (+2.12%)
BABA   210.17 (+2.21%)
MU   52.38 (+0.52%)
GE   10.91 (-3.71%)
AMD   47.75 (+0.38%)
T   37.29 (-0.16%)
ACB   1.52 (+0.66%)
F   7.26 (+0.28%)
NFLX   378.54 (+5.12%)
BAC   30.75 (-1.06%)
DIS   123.43 (-3.71%)
S&P 500   3,127.79 (-0.01%)
DOW   27,036.83 (-0.16%)
QQQ   217.04 (+0.78%)
AAPL   292.44 (+1.51%)
MSFT   170.50 (+1.45%)
GOOGL   1,397.80 (+0.83%)
AMZN   1,982.17 (+0.48%)
CGC   19.83 (+1.07%)
NVDA   267.60 (+2.12%)
BABA   210.17 (+2.21%)
MU   52.38 (+0.52%)
GE   10.91 (-3.71%)
AMD   47.75 (+0.38%)
T   37.29 (-0.16%)
ACB   1.52 (+0.66%)
F   7.26 (+0.28%)
NFLX   378.54 (+5.12%)
BAC   30.75 (-1.06%)
DIS   123.43 (-3.71%)
S&P 500   3,127.79 (-0.01%)
DOW   27,036.83 (-0.16%)
QQQ   217.04 (+0.78%)
AAPL   292.44 (+1.51%)
MSFT   170.50 (+1.45%)
GOOGL   1,397.80 (+0.83%)
AMZN   1,982.17 (+0.48%)
CGC   19.83 (+1.07%)
NVDA   267.60 (+2.12%)
BABA   210.17 (+2.21%)
MU   52.38 (+0.52%)
GE   10.91 (-3.71%)
AMD   47.75 (+0.38%)
T   37.29 (-0.16%)
ACB   1.52 (+0.66%)
F   7.26 (+0.28%)
NFLX   378.54 (+5.12%)
BAC   30.75 (-1.06%)
DIS   123.43 (-3.71%)
Log in

Aravive News Headlines (NASDAQ:ARAV)

$8.83
-0.12 (-1.34 %)
(As of 02/26/2020 03:17 PM ET)
Today's Range
$8.73
Now: $8.83
$9.09
50-Day Range
$8.94
MA: $10.77
$13.77
52-Week Range
$4.97
Now: $8.83
$15.62
Volume39,665 shs
Average Volume117,432 shs
Market Capitalization$129.36 million
P/E RatioN/A
Dividend YieldN/A
Beta2.49

Headlines

Aravive (NASDAQ ARAV) News Headlines

Source:
DateHeadline
Aravive To Present at The Cowen and Company 40th Annual Health Care Conference - Yahoo FinanceAravive To Present at The Cowen and Company 40th Annual Health Care Conference - Yahoo Finance
finance.yahoo.com - February 25 at 10:50 PM
Aravive To Present at The Cowen and Company 40th Annual Health Care ConferenceAravive To Present at The Cowen and Company 40th Annual Health Care Conference
finance.yahoo.com - February 25 at 5:49 PM
Cantor Fitzgerald Reiterates Overweight Rating on Aravive Inc. (ARAV) - StreetInsider.comCantor Fitzgerald Reiterates Overweight Rating on Aravive Inc. (ARAV) - StreetInsider.com
www.streetinsider.com - February 24 at 7:08 AM
Aravive Inc. (ARAV) Announces Dose Escalation in Phase 1b Trial of Cancer Drug AVB-500 - StreetInsider.comAravive Inc. (ARAV) Announces Dose Escalation in Phase 1b Trial of Cancer Drug AVB-500 - StreetInsider.com
www.streetinsider.com - February 20 at 11:48 PM
Aravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial - Yahoo FinanceAravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial - Yahoo Finance
finance.yahoo.com - February 19 at 11:32 PM
HC Wainwright Reiterates Buy Rating for Aravive (NASDAQ:ARAV)HC Wainwright Reiterates Buy Rating for Aravive (NASDAQ:ARAV)
www.americanbankingnews.com - February 19 at 7:49 AM
Form 8-K Aravive, Inc. For: Feb 18 - StreetInsider.comForm 8-K Aravive, Inc. For: Feb 18 - StreetInsider.com
www.streetinsider.com - February 18 at 8:25 AM
Aravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial - GlobeNewswireAravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial - GlobeNewswire
www.globenewswire.com - February 18 at 8:25 AM
Aravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b TrialAravive Announces Dose Escalation of AVB-500 in Recurrent Platinum Resistant Ovarian Cancer Phase 1b Trial
finance.yahoo.com - February 18 at 8:25 AM
Aravive Inc (NASDAQ:ARAV) Receives Average Rating of "Buy" from AnalystsAravive Inc (NASDAQ:ARAV) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - February 15 at 11:12 AM
Aravive Inc (NASDAQ:ARAV) Sees Large Increase in Short InterestAravive Inc (NASDAQ:ARAV) Sees Large Increase in Short Interest
www.americanbankingnews.com - February 12 at 8:44 PM
 Brokerages Expect Aravive Inc (NASDAQ:ARAV) to Post -$0.48 EPS Brokerages Expect Aravive Inc (NASDAQ:ARAV) to Post -$0.48 EPS
www.americanbankingnews.com - February 4 at 8:46 PM
Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma - Yahoo FinanceAravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma - Yahoo Finance
finance.yahoo.com - January 13 at 5:29 PM
Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell CarcinomaAravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma
finance.yahoo.com - January 13 at 5:29 PM
Aravive Announces Management Changes - Yahoo FinanceAravive Announces Management Changes - Yahoo Finance
finance.yahoo.com - January 11 at 4:50 PM
Aravive names new chief executiveAravive names new chief executive
seekingalpha.com - January 10 at 3:39 PM
BRIEF-Aravive Says Jay Shepard To Assume Role Of Chairman Of BoardBRIEF-Aravive Says Jay Shepard To Assume Role Of Chairman Of Board
www.msn.com - January 9 at 10:03 PM
Aravive Announces Management ChangesAravive Announces Management Changes
finance.yahoo.com - January 9 at 5:00 PM
3 Healthcare Stocks Primed for 2020 Gains3 Healthcare Stocks Primed for 2020 Gains
finance.yahoo.com - January 2 at 3:32 PM
Is Aravive, Inc. (ARAV) A Good Stock To Buy?Is Aravive, Inc. (ARAV) A Good Stock To Buy?
finance.yahoo.com - December 23 at 11:16 PM
Aravive launches mid-stage study of AVB-500 in kidney disorderAravive launches mid-stage study of AVB-500 in kidney disorder
seekingalpha.com - December 20 at 12:32 PM
Aravive Initiates a Phase 2a Clinical Trial of AVB-500 in Patients with Kidney FibrosisAravive Initiates a Phase 2a Clinical Trial of AVB-500 in Patients with Kidney Fibrosis
finance.yahoo.com - December 20 at 12:32 PM
Cantor likes Aravive in premarket analyst actionCantor likes Aravive in premarket analyst action
seekingalpha.com - December 10 at 1:21 PM
Aravive Announces Participation at the 2019 Piper Jaffray Healthcare ConferenceAravive Announces Participation at the 2019 Piper Jaffray Healthcare Conference
finance.yahoo.com - December 2 at 12:57 PM
Implied Volatility Surging for Aravive (ARAV) Stock OptionsImplied Volatility Surging for Aravive (ARAV) Stock Options
finance.yahoo.com - November 29 at 9:43 AM
The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For QiagenThe Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
www.msn.com - November 27 at 9:23 AM
Aravive down 20% premarket on pricing equity offeringAravive down 20% premarket on pricing equity offering
seekingalpha.com - November 27 at 9:23 AM
Aravive Announces Pricing of Public Offering of Common StockAravive Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - November 27 at 9:23 AM
Aravive -12.8% on proposed equity offeringAravive -12.8% on proposed equity offering
seekingalpha.com - November 26 at 7:32 PM
Aravive Announces Proposed Public Offering of Common StockAravive Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 26 at 7:32 PM
A Big Step Forward in the Fight Against Ovarian CancerA Big Step Forward in the Fight Against Ovarian Cancer
www.msn.com - November 20 at 2:50 PM
Biotech Stock Up Over 105% on Upbeat Cancer Drug DataBiotech Stock Up Over 105% on Upbeat Cancer Drug Data
finance.yahoo.com - November 20 at 2:50 PM
Here's Why This Tiny Biotech Stock Doubled In Value OvernightHere's Why This Tiny Biotech Stock Doubled In Value Overnight
finance.yahoo.com - November 20 at 2:50 PM
TGT, MYOV among premarket gainersTGT, MYOV among premarket gainers
seekingalpha.com - November 20 at 9:34 AM
Aravive rockets 263% premarket on promise of lead candidateAravive rockets 263% premarket on promise of lead candidate
seekingalpha.com - November 20 at 9:34 AM
Aravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian CancerAravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer
finance.yahoo.com - November 20 at 9:34 AM
Aravive shares jump on ovarian cancer dataAravive shares jump on ovarian cancer data
finance.yahoo.com - November 20 at 9:34 AM
CORRECTION – Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate UpdatesCORRECTION – Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
finance.yahoo.com - November 8 at 2:56 PM
Aravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate UpdatesAravive Reports Third Quarter 2019 Financial Results and Provides Recent Corporate Updates
finance.yahoo.com - November 7 at 5:19 PM
Does Aravive, Inc.'s (NASDAQ:ARAV) CEO Salary Compare Well With Others?Does Aravive, Inc.'s (NASDAQ:ARAV) CEO Salary Compare Well With Others?
finance.yahoo.com - November 3 at 8:29 AM
Aravive Announces Publication of AVB-500 Nonclinical Study in Treatment-Resistant ccRCC Animal Models in Cancer ResearchAravive Announces Publication of AVB-500 Nonclinical Study in Treatment-Resistant ccRCC Animal Models in Cancer Research
finance.yahoo.com - October 18 at 8:56 AM
Aravive Announces Participation at the 2019 Cantor Global Healthcare ConferenceAravive Announces Participation at the 2019 Cantor Global Healthcare Conference
finance.yahoo.com - September 27 at 5:07 PM
Aravive Presents Positive Data from Initial 12 Patients in Phase 1b Portion of its Phase 1b/2 Ovarian Cancer Study of AVB-500 in Late Breaking Oral Presentation at European Society for Medical Oncology Congress in BarcelonaAravive Presents Positive Data from Initial 12 Patients in Phase 1b Portion of its Phase 1b/2 Ovarian Cancer Study of AVB-500 in Late Breaking Oral Presentation at European Society for Medical Oncology Congress in Barcelona
finance.yahoo.com - September 27 at 5:07 PM
Will Aravive, Inc. (NASDAQ:ARAV) Need To Raise More Money?Will Aravive, Inc. (NASDAQ:ARAV) Need To Raise More Money?
finance.yahoo.com - September 21 at 1:26 AM
Aravive to Present Late-Breaking Oral Presentation at European Society for Medical Oncology Congress 2019 in BarcelonaAravive to Present Late-Breaking Oral Presentation at European Society for Medical Oncology Congress 2019 in Barcelona
finance.yahoo.com - September 18 at 10:26 AM
Aravive (ARAV) Presents At Wedbush PacGrow Healthcare Conference - SlideshowAravive (ARAV) Presents At Wedbush PacGrow Healthcare Conference - Slideshow
seekingalpha.com - August 15 at 8:41 PM
Aravive Announces Executive Management Transition PlanAravive Announces Executive Management Transition Plan
finance.yahoo.com - August 8 at 8:42 PM
Aravive Announces Participation at Wedbush PacGrow Healthcare ConferenceAravive Announces Participation at Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 8 at 8:45 AM
Aravive (ARAV) Reports Q2 Loss, Tops Revenue EstimatesAravive (ARAV) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 7 at 11:45 PM
Aravive Reports Second Quarter 2019 Financial Results and Provides Recent Corporate UpdatesAravive Reports Second Quarter 2019 Financial Results and Provides Recent Corporate Updates
finance.yahoo.com - August 7 at 6:45 PM
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Featured Article: What is the S&P/TSX Index?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel